SCHEMBL5315833

SCHEMBL5315833

O=C(CCn1c2ccccc2c2ccc(OCCCCOc3cccc(F)c3)cc21)OC(=O)CCn1c2ccccc2c2ccc(OCCCCOc3cccc4c3CCCC4=O)cc21

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MRGPRX4 Q96LA9 1/20 0.40
PSEN1 P49768 11/20 0.38
PSEN2 P49810 11/20 0.38
APH1B Q8WW43 11/20 0.38
NCSTN Q92542 11/20 0.38
APH1A Q96BI3 11/20 0.38
PSENEN Q9NZ42 11/20 0.38
FNTA P49354 1/20 0.36
FNTB P49356 1/20 0.36
HTR7 P34969 1/20 0.36
KCNA3 P22001 1/20 0.35
BRD4 O60885 2/20 0.35
MAOA P21397 1/20 0.35
MAOB P27338 1/20 0.35
LTB4R Q15722 1/20 0.34
LTB4R2 Q9NPC1 1/20 0.34
LMNA P02545 1/20 0.34
HPGD P15428 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5156572 0.87 MRGPRX4 (0.46) MRGPRX4PSEN1PSEN2APH1BNCSTN
SCHEMBL5152540 0.82 PSEN1 (0.46) MRGPRX4PSEN1PSEN2APH1BNCSTN
SCHEMBL5151311 0.81 MRGPRX4 (0.47) MRGPRX4PSEN1PSEN2APH1BNCSTN
SCHEMBL5149581 0.80 MRGPRX4 (0.46) MRGPRX4PSEN1PSEN2APH1BNCSTN
SCHEMBL5156703 0.77 FABP4 (0.54) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL5156096 0.76 PSEN1 (0.45) MRGPRX4PSEN1PSEN2APH1BNCSTN
SCHEMBL5151495 0.75 PPARG (0.44) MRGPRX4PSEN1PSEN2APH1BNCSTN
SCHEMBL5315810 0.74 PSEN1 (0.43) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL5152291 0.73 MAOB (0.54) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL5319394 0.72 KMT2A (0.38) PSEN1PSEN2APH1BNCSTNAPH1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007071456-A1 FLUORENES AND CARBAZOLES AS LIGANDS OF THE EP2 RECEPTOR BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-06-28 WO disclosed